3 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Recruiting 3 |
Follow Large B-cell Lymphoma: new trials by email Literature Review of Large B-cell Lymphoma trials Research Report on Large B-cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy rondecabtagene autoleucel, axicabtagene ciloleucel, lisocabtagene maraleucel - Large B-cell Lymphoma, Lymphoma, B-Cell | Phase 3 | Recruiting | Lyell Immunopharma, Inc. | 400 | 2026-01-12 | 2026-08-04 |
| AZD0486 1L Therapy for Elderly or Unfit Participants With LBCL AZD0486, R-mini-CHOP - Large B-cell Lymphoma | Phase 3 | Recruiting | AstraZeneca | 420 | 2025-11-11 | 2026-10-09 |
| Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma R-miniCHOP + Acalabrutinib, R-miniCHOP - Large B-cell Lymphoma, Diffuse Large B Cell Lymphoma | Phase 3 | Recruiting | Universität des Saarlandes | 330 | 2023-06-07 | 2026-06-29 |
Lymphoma, Large B-Cell, Diffuse (2) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Non-Hodgkin (1)
Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Non-Hodgkin (1)
acalabrutinib (1) · axicabtagene ciloleucel (1)
AstraZeneca (1) · Lyell Immunopharma, Inc. (1) · Universität des Saarlandes (1)
Germany (2) · Australia (1) · Belgium (1) · Brazil (1) · Canada (1) · China (1) · Hong Kong (1) · Japan (1) · Poland (1) · South Korea (1) · Turkey (Türkiye) (1) · United Kingdom (1) · United States (1)
Konstantinos Christofyllakis, MD MSc (1) · Michael Dickinson,, MBBS BS DMSc (1) · Moritz Bewarder, MD, PD (1)
2025 (1)